COVID19 Neurological Manifestation

Completed

Conditions studied: SARS-CoV 2, Neurologic Manifestations

In brief

This study is a prospective observational cohort study to document the prevalence and types of neurological manifestations among hospitalized patients with confirmed or suspected novel coronavirus infection (COVID-19).

Key facts

Study ID

NCT04496128

Run by

University of Pittsburgh

People needed

300

Starts

2020-04-13

Expected to finish

2021-05-30

Last updated by the study team

2021-08-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients greater than or equal to 18 years old
• Admitted with suspected or confirmed COVID19 infection
• Patient exhibiting acute neurological symptoms

You may not qualify if…

• Patients under the age of 18 years old
• Pre-existing, baseline severe neurologic dysfunction including baseline coma/vegetative state, baseline quadriparesis, baseline refractory seizure disorder with frequent breakthrough seizures despite anticonvulsant use

Where it is running

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.